BOP2FE
1.0.3Bayesian Optimal Phase II Design with Futility and Efficacy Stopping Boundaries
Overview
Bayesian optimal design with futility and efficacy stopping boundaries (BOP2-FE) is a novel statistical framework for single-arm Phase II clinical trials. It enables early termination for efficacy when interim data are promising, while explicitly controlling Type I and Type II error rates. The design supports a variety of endpoint structures, including single binary endpoints, nested endpoints, co-primary endpoints, and joint monitoring of efficacy and toxicity. The package provides tools for enumerating stopping boundaries prior to trial initiation and for conducting simulation studies to evaluate the design’s operating characteristics. Users can flexibly specify design parameters to suit their specific applications. For methodological details, refer to Xu et al. (2025) doi:10.1080/10543406.2025.2558142.
Install
Health
- OK2026-03-1014 OK · 0 NOTE · 0 WARNING · 0 ERROR · 0 FAILURE
Documentation
Documentation signals are not tracked yet for this package.
Downloads
Repository
Repository practices
4 development-tooling and community-health practices detected across 4 families in the upstream repository
Checks run against github.com/belayb/bop2fe on 2026-07-19.
Dependencies
Code & Tests
People & History
1 release. R releases are shown for context.
- RR 4.6.0 released · 2026-04-24
- 1.0.3Latest2026-03-10 · current release
- RR 4.5.0 released · 2025-04-11
Package metadata
- First published
- 2025-09-29
- Total releases
- 1 / 1 yrs
- License
- MIT + file LICENSE OSI
- Download size
- 436 KB
- Installed size
- not tracked yet
- With dependencies
- not tracked yet